Daily Medical Update

Lower gastrointestinal hemorrhage

Wednesday, September 30, 2026

🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the last 12 months.

1. American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in acute lower gastrointestinal bleeding.

Gastrointestinal endoscopy (2026) - Practice Guideline

Key Findings

  • The GRADE-based recommendations support improved initial triage by defining decisions between colonoscopy and CT +/- angiography.
  • The guideline provides lesion-specific recommendations intended to improve diverticular hemostasis decisions, including band ligation versus clipping and direct versus indirect clip closure.

📋 Practice Implication: Use the guideline to structure initial imaging and endoscopic triage, then tailor diverticular hemostasis choices to the lesion and clinical context.

2. Risk factors for rebleeding in acute lower gastrointestinal bleeding: a systematic review and meta-analysis.

International journal of colorectal disease (2026) - Meta-Analysis

Key Findings

  • Among 14,069 patients, 1,930 experienced rebleeding (13.7%).
  • Multivariable analysis associated age 70 years or older, transfusion, shock, hypertension, chronic kidney disease, hyperlipidemia, NSAID use, active bleeding, diverticular bleeding, and non-aspirin antiplatelet treatment with increased rebleeding risk.
  • Steroid, aspirin, and anticoagulant use were also associated with increased rebleeding risk in univariable analysis.

📋 Practice Implication: At presentation, use age, shock, transfusion needs, comorbidities, medications, and active bleeding to identify patients needing closer surveillance for recurrence.

3. Endoscopic therapies for colonic diverticular bleeding: a systematic review and meta-analysis.

Surgical endoscopy (2025) - Meta-Analysis

Key Findings

  • Endoscopic treatment achieved a pooled successful hemostasis rate of 98.90% (95% CI 97.66%-99.75%) across 3,161 participants.
  • TTS clips were consistently associated with worse early and late rebleeding outcomes, longer procedure time, and increased need for transcatheter arterial embolization or surgery.
  • There were no significant differences in hospital stay or mortality; EDSL had the highest pooled overall adverse-event rate at 2.15%.

📋 Practice Implication: For colonic diverticular bleeding, choose an endoscopic modality supported by local expertise while recognizing that TTS clips may have less favorable effectiveness outcomes than alternatives.

4. Efficacy and safety of transcatheter arterial embolization for lower gastrointestinal bleeding: a systematic review and meta-analysis of 58 clinical trials.

European journal of medical research (2025) - Meta-Analysis

Key Findings

  • Across 2,262 patients, TAE had a technical success rate of 97.7% and a clinical success rate of 75.0%.
  • The pooled rebleeding rate was 17.3%, major complications occurred in 4.3%, mild ischemia in 4.7%, and secondary complications in 10.8%.
  • After 2010, overall ischemic events decreased from 12.7% to 6.3%, indicating improved safety over time.

📋 Practice Implication: When endoscopic control is unsuccessful or impractical, TAE offers a high-technical-success rescue pathway, but referral should include counseling about rebleeding and ischemic complications.

5. Proton pump inhibitors for prevention of upper and lower gastrointestinal bleeding in patients taking aspirin: a systematic review and meta-analysis.

European journal of clinical pharmacology (2026) - Meta-Analysis

Key Findings

  • PPIs reduced upper gastrointestinal bleeding versus placebo or no treatment (RR 0.30 versus placebo/blank in seven RCTs; RR 0.50 versus no PPI in seven non-RCTs).
  • PPI use was associated with increased lower gastrointestinal bleeding versus no PPI (RR 2.85, 95% CI 1.85-4.38), based on non-randomized evidence.
  • Lower gastrointestinal bleeding risk did not differ significantly between PPIs and H2-receptor antagonists (RR 1.88, 95% CI 0.30-11.82).

📋 Practice Implication: In aspirin users, reserve PPI gastroprotection for a reasoned balance of strong upper-bleeding prevention against the observational lower-bleeding signal, with reassessment of ongoing need.

💡 Summary

The strongest evidence identifies clinical and treatment-related predictors of recurrent acute lower gastrointestinal bleeding and supports high immediate hemostasis rates for endoscopic therapy. Transcatheter arterial embolization provides high technical success when intervention is needed, while the ASGE guideline organizes modality and timing decisions. In aspirin users, PPIs reduce upper gastrointestinal bleeding but are associated with a potential increase in lower gastrointestinal bleeding in non-randomized evidence.

Generated from 120 PubMed abstracts · RCTs and Meta-analyses only

Next topic: Idiopathic pulmonary fibrosis

Unsubscribe  ·  Subscribe